Target Pharmasolutions, Inc.
Clinical trials sponsored by Target Pharmasolutions, Inc., explained in plain language.
-
Long-Term PBC study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study followed 711 adults with primary biliary cholangitis (PBC) for 5 years to learn how the disease is treated in everyday medical practice. Researchers collected data on treatment regimens, patient groups often left out of drug trials, and side effects. The goal was to be…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:41 UTC
-
Massive Real-World study tracks fatty liver disease and current treatments
Knowledge-focused CompletedThis study followed over 7,300 patients with nonalcoholic fatty liver disease (NAFLD) or its more serious form, NASH, in regular doctor visits. The goal was to learn how the disease progresses over time and how doctors currently treat it, since no FDA-approved medicines exist yet…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:38 UTC
-
Researchers track COVID-19 patients to uncover disease secrets
Knowledge-focused CompletedThis study followed 199 adults hospitalized with COVID-19 to better understand the disease. Researchers collected information on patient backgrounds, treatments used, and how the illness progressed over time. The goal was to answer important questions about COVID-19 without testi…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC